about
Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytesFcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease.Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3.Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus.Drug Hypersensitivity and Desensitizations: Mechanisms and New ApproachesDevelopment of a two-part strategy to identify a therapeutic human bispecific antibody that inhibits IgE receptor signaling.Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architectureA new self: MHC-class-I-independent natural-killer-cell self-tolerance.Cis binding between inhibitory receptors and MHC class I can regulate mast cell activationFc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells.Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo.Potential effector and immunoregulatory functions of mast cells in mucosal immunity.Eosinophils unleashedCis interactions of immunoreceptors with MHC and non-MHC ligands.Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell ActivationThe multiple roles of phosphoinositide 3-kinase in mast cell biology.Maternal immunization to modulate the development of allergic response and pathogen infections.Cbl family proteins: balancing FcεRI-mediated mast cell and basophil activation.Immunoglobulin E receptor signaling and asthmaState-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?Immunology and clinical manifestations of non-clonal mast cell activation syndromeThe Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer's Disease.Mannose receptor and macrophage galactose-type lectin are involved in Bordetella pertussis mast cell interaction.Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity.Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.Selective inhibition of the Fc epsilon RI-induced de novo synthesis of mediators by an inhibitory receptor.Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway responseMolecular dissection of the FcRbeta signaling amplifier.Development of an in vitro system for the study of allergens and allergen-specific immunoglobulin E and immunoglobulin G: Fcepsilon receptor I supercross-linking is a possible new mechanism of immunoglobulin G-dependent enhancement of type I allergiCD300 family receptors regulate eosinophil survival, chemotaxis, and effector functions.
P2860
Q28592638-39BD2CE3-615E-4569-864E-A488B18BE70EQ30664429-F545F255-9B32-417B-A255-365E8E3D4FB3Q31109562-1CC0665E-DDF0-47EA-8B98-66B973AEF130Q33668011-47F920E8-B194-4461-8D7B-6C4D72645216Q33839145-8D2F1B0C-686E-46AB-B1AB-A8E7B81A6E02Q33966937-ED2DF5E0-9DDC-4FE9-966D-C1A2D3A0230DQ35731892-BB7EE240-554C-4F67-920F-D655B2FEA436Q36102621-F5F3E651-4608-45F9-AD3C-E0D477AD87E3Q36229245-BD52E243-37D6-4026-A709-274270B81282Q36330511-761A47E7-2BDC-41D8-A0E7-E61395476B91Q36403209-499E89C7-FC5E-4E96-8361-7542261F511AQ36539857-3B567695-5F50-47FC-8F1A-8630BAAF9B74Q36713483-A2A10590-60DB-44EC-A4C7-7123DDE8F089Q36800512-35DF33C6-B61E-4F66-9360-81C3F0FFCDAEQ36912495-BA0FEDE6-FEB1-45A1-ADC5-D19501D1DE1FQ37252679-44FE4CE3-F8C1-4B4F-BC0A-DEE10C3CFDC2Q37773283-07BF7E7D-EA52-4FE7-AB70-2FF9051691E0Q37859217-2D11598E-9100-4F94-A107-82EB6CB7E751Q37907670-E79059BE-C095-4FAA-9EC0-6AFF3146FEF7Q37975604-61A12A8C-7BB8-4300-BC74-8009767BF074Q38065108-02C58610-AEB9-460F-8C47-4D1ACD1E9FA8Q38281324-3270E2C0-3359-47C3-A109-B0B817E6B2ECQ38314624-0703420C-1481-4C4B-9DE1-BC3BC3EE8753Q39035492-AB4ED5B9-598C-4854-9F26-8F050FADD2EAQ41895016-6EC78A3C-67D4-489A-9A56-BD614D596115Q42029817-95A267DD-50D6-47F9-9FB9-3A6B744B2B2BQ42696903-DC1CC459-71BE-4971-9284-574D2D106903Q45038646-6B0474FB-1A90-4AC9-9F53-B4C1A38999B9Q46559696-E32BFFA6-3413-4744-9CD5-5208FE9D5FF0Q49973003-F3549E2F-BAB1-4E2F-A076-DEA0D7C12B9D
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inhibitory receptors and allergy.
@ast
Inhibitory receptors and allergy.
@en
Inhibitory receptors and allergy.
@nl
type
label
Inhibitory receptors and allergy.
@ast
Inhibitory receptors and allergy.
@en
Inhibitory receptors and allergy.
@nl
prefLabel
Inhibitory receptors and allergy.
@ast
Inhibitory receptors and allergy.
@en
Inhibitory receptors and allergy.
@nl
P1476
Inhibitory receptors and allergy.
@en
P2093
Howard R Katz
P304
P356
10.1016/S0952-7915(02)00400-4
P577
2002-12-01T00:00:00Z